H05BX02 • paricalcitol • Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Other anti-parathyroid agents
Paricalcitol is a vitamin D analog used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. It helps regulate calcium and phosphorus levels in the body, reducing excessive secretion of parathyroid hormone (PTH).
The medication is administered intravenously or orally, as directed by your doctor. It is important to monitor calcium, phosphorus, and PTH levels during treatment to prevent complications.
Side effects may include nausea, itching, hypercalcemia, or, in rare cases, severe allergic reactions.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as bone or kidney diseases, to ensure the safe use of paricalcitol.
Substance: paricalcitol
Date of last drug list: 01-05-2026
Commercial code: W63198001
Concentration: 5mcg / ml
Pharmaceutical form: solution for injection
Packing volume: 1 ml
Product type: original
Price: 329.76 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: ABBVIE S.R.L. - ITALIA
Holder: ABBVIE SPAIN S.L.U. - SPANIA
Number: 9420/2016/01
Shelf life: 2 years
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
Price
Copayment
Patient
329.76 RON
213.17 RON
116.59 RON
NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure
Price
Copayment
Patient
329.76 RON
213.17 RON
116.59 RON